CMTM5 is widely expressed in normal tissues and its expression levels are either downregulated or silenced in liver (Guan et al., 2018), kidney (Cai et al., 2017), and prostate (Xiao et al., 2015) cancers. The gene discussed is CMTM5; the disease is cancer.